The March 2024 quarter revenue stood at Rs. 9108.70 millions, up 16.46% as compared to Rs. 7821.60 millions during the corresponding quarter last year.A comparatively good net profit growth of 46.85% to Rs. 1930.80 millions was reported for the quarter ended March 2024 compared to Rs. 1314.80 millions of previous same quarter.Operating Profit saw a handsome growth to 2851.80 millions from 1947.30 millions in the quarter ended March 2024.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202403 202303 % Var 202403 202303 % Var 202403 202303 % Var
Sales 9108.70 7821.60 16.46 34072.50 32163.40 5.94 34072.50 32163.40 5.94
Other Income 298.70 279.70 6.79 1234.80 1015.20 21.63 1234.80 1015.20 21.63
PBIDT 2851.80 1947.30 46.45 10241.30 9009.30 13.67 10241.30 9009.30 13.67
Interest 7.70 6.50 18.46 18.00 18.10 -0.55 18.00 18.10 -0.55
PBDT 2868.10 2044.80 40.26 8787.20 8981.50 -2.16 8787.20 8981.50 -2.16
Depreciation 181.00 171.80 5.36 696.80 657.70 5.94 696.80 657.70 5.94
PBT 2687.10 1873.00 43.47 8090.40 8323.80 -2.80 8090.40 8323.80 -2.80
TAX 756.30 558.20 35.49 2243.50 2276.80 -1.46 2243.50 2276.80 -1.46
Deferred Tax 144.70 -7.60 -2003.95 -113.60 -183.70 -38.16 -113.60 -183.70 -38.16
PAT 1930.80 1314.80 46.85 5846.90 6047.00 -3.31 5846.90 6047.00 -3.31
Equity 1694.10 1694.10 0.00 1694.10 1694.10 0.00 1694.10 1694.10 0.00
PBIDTM(%) 31.31 24.90 25.76 30.06 28.01 7.31 30.06 28.01 7.31

Glaxosmithkline Phar Share Price

2630.60 37.60 (1.45%)
31-May-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1462.50
Dr. Reddys Lab 5784.50
Cipla 1451.25
Zydus Lifesciences 1001.15
Lupin 1587.90
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.